FIELD: biotechnology.
SUBSTANCE: present invention refers to new immunogens based on overlapping peptides (OLP), and can be used in medicine for preventing or treating HIV infection. Immunogenic fused protein consisting of polypeptide segments connected by amino acid linkers is obtained. Present invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens, as well as vaccines containing said immunogens.
EFFECT: invention provides induction of HIV-specific T-cell immune responses in a host.
36 cl, 8 dwg, 5 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
VIRUS-LIKE PARTICLES WITH HIGH-DENSITY COATING FOR INDUCTION OF ANTIBODY EXPRESSION | 2017 |
|
RU2813282C2 |
IMMUNOGENIC COMPOSITION AGAINST SUBTYPE H5 AVIAN FLU VIRUS | 2019 |
|
RU2809084C2 |
GENE THERAPY OF HYPOPHOSPHATEMIC DISEASES ASSOCIATED WITH FIBROBLAST GROWTH FACTOR 23 | 2020 |
|
RU2815545C2 |
BISPECIFIC ANTIBODY | 2020 |
|
RU2814713C2 |
IL2 AND MUTANT TNF IMMUNOCONJUGATES | 2017 |
|
RU2758139C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF MALIGNANT TUMOR | 2019 |
|
RU2781542C2 |
IMMUNOCYTOKINES BASED ON IL-15 AND IL-15Rα OF THE SUSHI DOMAIN | 2012 |
|
RU2763298C2 |
MATERIALS AND METHODS USED FOR TREATMENT OF RESPIRATORY DISEASES IN DOGS | 2020 |
|
RU2811752C2 |
PNEUMOCOCCAL VACCINE COMBINING SELECTED ALPHA HELICAL DOMAINS AND PROLINE-RICH DOMAINS OF PNEUMOCOCCAL SURFACE PROTEIN A | 2017 |
|
RU2794625C2 |
HOMOLOGUE OF GLYCEROL-3-PHOSPHATE-ACYLTRANSFERASE AND APPLICATION THEREOF | 2011 |
|
RU2545375C2 |
Authors
Dates
2020-05-18—Published
2013-01-28—Filed